Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Fakas N"'
Autor:
Giannouli E; Headache Clinic, Athens Medical Centre: Omilos Iatrikou Athinon, 5-7 Distomou Street, Marousi, Athens, Greece. ergiannouli@hotmail.com., Giannouli E; 1st Psychiatric Clinic, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Alexoudi A; First Department of Neurosurgery, Evangelismos Hospital, Medical School, National and Kapodistrian University of Athens, Neurological Institute of Athens, Athens, Greece., Arvaniti C; Second Department, Medical School, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece., Fakas N; Neurology Department, 401 General Military Hospital, Athens, Greece., Constantinidis TS; Neurology Clinic, Korinthos, Greece., Kouremenos E; Neurology Department, 251 General Hospital of Air Forces, Athens, Greece., Mitsikostas DD; First Department of Neurology, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2024 Jul 15; Vol. 8 (1), pp. 72. Date of Electronic Publication: 2024 Jul 15.
Publikováno v:
In Pulmonology November-December 2021 27(6):572-574
Autor:
Constantinidis TS; Hellenic Headache Society, Athens, Greece., Arvaniti C; Attikon University Hospital, Chaidari, Greece., Fakas N; Neurology Department, 401 Army General Hospital of Athens, Athens, Greece., Rudolf J; Department of Neurology, Papageorgiou General Hospital, Thessaloniki, Greece., Kouremenos E; Neurology Department, 251 Air Forces General Hospital of Athens, Athens, Greece., Giannouli E; Department of Neurology, Athens Medical Center, Athens, Greece., Mitsikostas DD; First Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
Cephalalgia : an international journal of headache [Cephalalgia] 2023 Jun; Vol. 43 (6), pp. 3331024231184909.
Autor:
Mitsikostas DD; Department of Neurology, Athens Naval Hospital, Athens, Greece., Orologas A; A' Department of Neurology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece., Dardiotis E; Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece., Fakas N; Neurology Department, General Military Hospital of Athens, 401, Athens, Greece., Doskas T; Ntoskas K. Triantafillos Private Practice, K. Papakonstantinou 4, Paiania, 19002, Athens, Greece., Karageorgiou K; The Neurological Institute of Athens, 51, Leof. Vasilissis Sofias Ave, 10676, Athens, Greece., Maltezou M; Department of Neurology, General Oncology Hospital of Kifissia 'Agioi Anargiroi', Athens, Greece., Iliopoulos I; Department of Neurology, University Hospital of Alexandroupolis, Alexandroupolis, Greece., Vikelis M; Novartis Hellas SACI, Athens, Greece., Grigoriadis N; B' Department of Neurology, School of Medicine, Faculty of Health Sciences, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA University Hospital, Kiriakidi 1, 54621, Thessaloniki, Greece. ngrigoriadis@auth.gr.
Publikováno v:
Advances in therapy [Adv Ther] 2023 May; Vol. 40 (5), pp. 2217-2233. Date of Electronic Publication: 2023 Mar 10.
Autor:
Simeakis G; Endocrine Department, 401 General Military Hospital of Athens, 115 25 Athens, Greece.; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece., Anagnostouli M; Multiple Sclerosis and Demyelinating Diseases Unit, 1st Neurology Department, School of Medicine, Aeginition University Hospital, National and Kapodistrian University of Athens, 115 28 Athens, Greece., Fakas N; Neurology Department, 401 General Military Hospital of Athens, 115 25 Athens, Greece., Koutsikos J; Department of Nuclear Medicine, 401 Military Hospital of Athens, 115 25 Athens, Greece., Papatheodorou A; Department for Biomedical Research, 251 Air Force General Hospital, 115 25 Athens, Greece., Chanopoulos K; Center for Molecular Biology-Research Unit, 401 Military Hospital of Athens, 115 25 Athens, Greece., Athanasiou K; Department of Nuclear Medicine, 401 Military Hospital of Athens, 115 25 Athens, Greece., Papatheodorou G; Center for Molecular Biology-Research Unit, 401 Military Hospital of Athens, 115 25 Athens, Greece., Zapanti E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece., Alevizaki M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece., Kaltsas G; Endocrine Oncology Unit, First Department of Propaedeutic and Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, 115 27 Athens, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
Publikováno v:
Biomedicines [Biomedicines] 2023 Feb 17; Vol. 11 (2). Date of Electronic Publication: 2023 Feb 17.
Introduction: The efficacy of prolonged-release fampridine (PR-FAM) may extend in multiple sclerosis (MS) beyond walking ability. The objective of this study was to evaluate the effect of PR-FAM treatment on cognition, fatigue, depression, and qualit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::5545808bef140a679164eceb9c6adfb0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102731
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102731
Objective: To estimate the prevalence, burden and current treatment of disabling primary headaches in a large sample of the Greek population aged 18–70 years old. Methods: This is an observational descriptive study, with cross-sectional design perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::be7b1b9fe205c51a9957e5406f18d105
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119663
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119663
Background: Little is known about whether tolerability and adherence to treatment can be influenced by weather and temperature conditions. The objective of this study was to assess monthly and seasonal adherence to and safety of sc IFN-β1a (Rebif®,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::60f378fdebfe2318b5ca03c52ceb9986
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106854
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106854
Autor:
Constantinidis TS; Hellenic Headache Society, Athens, Greece., Arvaniti C; Second Neurology Department, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Fakas N; Neurology Department, 401 Army General Hospital of Athens, Athens, Greece., Rudolf J; Department of Neurology, Papageorgiou General Hospital, Thessaloniki, Greece., Kouremenos E; 251 Air Forces General Hospital of Athens, Neurology Department, Leof. Pan. Kannelopoulou, Athens, Greece., Giannouli E; Department of Neurology, Athens Medical Center, 5-7 Distomou, Marousi, Athens, Greece., Mitsikostas DD; First Neurology Department, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
Cephalalgia : an international journal of headache [Cephalalgia] 2021 Jun; Vol. 41 (7), pp. 810-820. Date of Electronic Publication: 2021 Feb 01.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.